Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
22
Number of overlapping holdings
6.2%
% of FHLC's 372 holdings also in MEDX
73.3%
% of MEDX's 30 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.2% | 15.1% | 10.2% |
|
MERCK & CO. INC. | 5.2% | 5.2% | 5.2% |
|
ABBVIE INC | 5.1% | 7.3% | 5.1% |
|
JOHNSON & JOHNSON | 6.3% | 4.5% | 4.5% |
|
PFIZER INC | 2.4% | 4.3% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 7.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
ABBOTT LABORATORIES | 3.3% |
|
DANAHER CORP | 2.9% |
|
INTUITIVE SURGICAL INC | 2.3% |
|
STRYKER CORP | 2.0% |
|
ELEVANCE HEALTH INC | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
 |
MEDTRONIC PLC | 1.8% |
|
JOHNSON & JOHNSON | 1.8% |
FHLC Underweight Relative to MEDX
 |
NOVARTIS AG-ADR | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.7% |
|
ELI LILLY & CO | -4.9% |
|
AMGEN INC | -3.7% |
|
BIOGEN IDEC INC | -3.6% |
|
ALKERMES PLC | -3.2% |
|
CRISPR THERAPEUTICS AG | -3.1% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -3.0% |
|
BRISTOL-MYERS SQUIBB CO | -3.0% |
|
IONIS PHARMACEUTICALS, INC. | -2.8% |